3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
361
Precursor Cell Lymphoblastic Leukemia-Lymphoma
328
Lymphoma
297
Leukemia
254
Multiple Myeloma
246
Leukemia, Myeloid, Acute
241
Lymphoma, Non-Hodgkin
240
Lymphoma, Large B-Cell, Diffuse
238
Leukemia, Lymphocytic, Chronic, B-Cell
220
Myelodysplastic Syndromes
184
Lymphoma, Follicular
176
Hodgkin Disease
165
Lymphoma, Mantle-Cell
163
Burkitt Lymphoma
160
Lymphoma, B-Cell, Marginal Zone
117
Recurrence
115
Lymphoma, Large-Cell, Immunoblastic
95
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Myeloproliferative Disorders
81
Melanoma
78
Neoplasms, Plasma Cell
77
Leukemia, Myeloid, Chronic-Phase
72
Hematologic Neoplasms
72
Leukemia, Myeloid, Accelerated Phase
71
Leukemia, Myelomonocytic, Chronic
69
Lymphoma, B-Cell
65
Dendritic Cell Sarcoma, Interdigitating
64
Triple Negative Breast Neoplasms
63
Ovarian Neoplasms
61
Congenital Abnormalities
59
Interventions
Specimen Handling
3
Paclitaxel
3
Nivolumab
3
Carboplatin
3
olaparib
2
X-Rays
2
Biopsy
2
sargramostim
1
pembrolizumab
1
pazopanib
1
pamiparib
1
liposomal doxorubicin
1
durvalumab
1
ceralasertib
1
cediranib
1
atezolizumab
1
apatinib
1
Trabectedin
1
Tissue Banks
1
TIC10 compound
1
Minimally Invasive Surgical Procedures
1
Magnetic Resonance Spectroscopy
1
LY-2157299
1
Indocyanine Green
1
Immunoglobulin G
1
Gemcitabine
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Cisplatin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinosarcoma
×
Cyclophosphamide
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled